Medtronic PLC (NYSE: MDT) has reported E.P.S. of $0.68 for its second fiscal quarter (ending October 31) versus $0.32 for the same period a year ago — an increase of 112%. For the latest four quarters through October 31, E.P.S. were $3.09 compared to $3.23 a year ago — a decline of -4%.
Recent Price Action
Medtronic PLC (NYSE: MDT) stock closed at $78.62 on 11/21/23 after a large increase of 4.6%. The stock has performed in line with the market over the last nine months and has risen 9.1% during the last week.
Current PriceTarget Research Rating
MDT’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Medtronic has a current Value Trend Rating of D (Negative). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Medtronic has a neutral Appreciation Score of 43 and a neutral Power Rating of 42, with the Negative Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment